Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 189

1.

Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Vorland CJ, Biruete A, Lachcik PJ, Srinivasan S, Chen NX, Moe SM, Hill Gallant KM.

J Bone Miner Res. 2019 Oct 16. doi: 10.1002/jbmr.3894. [Epub ahead of print]

PMID:
31618470
2.

Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).

Avin KG, Allen MR, Chen NX, Srinivasan S, O'Neill KD, Troutman AD, Mast G, Swallow EA, Brown MB, Wallace JM, Zimmers TA, Warden SJ, Moe SM.

J Am Soc Nephrol. 2019 Oct;30(10):1898-1909. doi: 10.1681/ASN.2019040349. Epub 2019 Sep 9.

PMID:
31501355
3.

Tester and testing procedure influence clinically determined gait speed.

Warden SJ, Kemp AC, Liu Z, Moe SM.

Gait Posture. 2019 Oct;74:83-86. doi: 10.1016/j.gaitpost.2019.08.020. Epub 2019 Aug 28.

PMID:
31491564
4.

Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing.

Swallow EA, Aref MW, Metzger CE, Sacks S, Lehmkuhler DR, Chen N, Hammond MA, Territo PR, Nickolas TL, Moe SM, Allen MR.

Bone. 2019 Oct;127:419-426. doi: 10.1016/j.bone.2019.07.007. Epub 2019 Jul 9.

PMID:
31299384
5.

Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.

Vorland CJ, Lachcik PJ, Swallow EA, Metzger CE, Allen MR, Chen NX, Moe SM, Hill Gallant KM.

Sci Rep. 2019 May 28;9(1):7936. doi: 10.1038/s41598-019-44415-9.

6.

Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.

Aref MW, Swallow EA, Metzger CE, Chen N, Moe SM, Allen MR.

Osteoporos Int. 2019 Aug;30(8):1693-1698. doi: 10.1007/s00198-019-04974-z. Epub 2019 May 8.

PMID:
31069439
7.

Time course of rapid bone loss and cortical porosity formation observed by longitudinal μCT in a rat model of CKD.

McNerny EMB, Buening DT, Aref MW, Chen NX, Moe SM, Allen MR.

Bone. 2019 Aug;125:16-24. doi: 10.1016/j.bone.2019.05.002. Epub 2019 May 3.

PMID:
31059864
8.

Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract.

Biruete A, Hill Gallant KM, Lindemann SR, Wiese GN, Chen NX, Moe SM.

J Ren Nutr. 2019 Mar 4. pii: S1051-2276(19)30004-4. doi: 10.1053/j.jrn.2019.01.004. [Epub ahead of print] Review.

PMID:
30846238
9.

Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.

Clinkenbeard EL, Noonan ML, Thomas JC, Ni P, Hum JM, Aref M, Swallow EA, Moe SM, Allen MR, White KE.

JCI Insight. 2019 Feb 21;4(4). pii: 123817. doi: 10.1172/jci.insight.123817. eCollection 2019 Feb 21.

10.

Comparison of Risk Factors for Pediatric Kidney Stone Formation: The Effects of Sex.

Schwaderer AL, Raina R, Khare A, Safadi F, Moe SM, Kusumi K.

Front Pediatr. 2019 Feb 12;7:32. doi: 10.3389/fped.2019.00032. eCollection 2019.

11.

Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.

Schwantes-An TH, Liu S, Stedman M, Decker BS, Wetherill L, Edenberg HJ, Vatta M, Foroud TM, Chertow GM, Moe SM.

Am J Nephrol. 2019;49(2):125-132. doi: 10.1159/000496060. Epub 2019 Jan 22.

PMID:
30669147
12.

Characterizing Dysgeusia in Hemodialysis Patients.

Fitzgerald C, Wiese G, Moorthi RN, Moe SM, Hill Gallant K, Running CA.

Chem Senses. 2019 Mar 11;44(3):165-171. doi: 10.1093/chemse/bjz001.

PMID:
30629153
13.

Effect of dietary phosphorus intake and age on intestinal phosphorus absorption efficiency and phosphorus balance in male rats.

Vorland CJ, Lachcik PJ, Aromeh LO, Moe SM, Chen NX, Hill Gallant KM.

PLoS One. 2018 Nov 19;13(11):e0207601. doi: 10.1371/journal.pone.0207601. eCollection 2018.

14.

Sudden cardiac death in patients undergoing dialysis: More than a single toxin.

Moe SM.

Heart Rhythm. 2019 Feb;16(2):318-319. doi: 10.1016/j.hrthm.2018.09.017. Epub 2018 Sep 24. No abstract available.

PMID:
30261293
15.

Effects of treadmill running in a rat model of chronic kidney disease.

Organ JM, Allen MR, Myers-White A, Elkhatib W, O'Neill KD, Chen NX, Moe SM, Avin KG.

Biochem Biophys Rep. 2018 Sep 14;16:19-23. doi: 10.1016/j.bbrep.2018.09.001. eCollection 2018 Dec.

16.

Pilot Study of the Effects of High-Protein Meals During Hemodialysis on Intradialytic Hypotension in Patients Undergoing Maintenance Hemodialysis.

Choi MS, Kistler B, Wiese GN, Stremke ER, Wright AJ, Moorthi RN, Moe SM, Hill Gallant KM.

J Ren Nutr. 2019 Mar;29(2):102-111. doi: 10.1053/j.jrn.2018.06.002. Epub 2018 Aug 11.

PMID:
30107974
17.

Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.

Moe SM, Long J, Schwantes-An TL, Decker BS, Wetherill L, Edenberg HJ, Xuei X, Vatta M, Foroud TM, Chertow GM.

Nephrol Dial Transplant. 2018 Jul 2. doi: 10.1093/ndt/gfy191. [Epub ahead of print]

PMID:
29982608
18.

Skeletal vascular perfusion is altered in chronic kidney disease.

Aref MW, Swallow EA, Chen NX, Moe SM, Allen MR.

Bone Rep. 2018 May 4;8:215-220. doi: 10.1016/j.bonr.2018.05.001. eCollection 2018 Jun.

19.

Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease.

Swallow EA, Aref MW, Chen N, Byiringiro I, Hammond MA, McCarthy BP, Territo PR, Kamocka MM, Winfree S, Dunn KW, Moe SM, Allen MR.

Osteoporos Int. 2018 Sep;29(9):2139-2146. doi: 10.1007/s00198-018-4589-3. Epub 2018 Jun 11.

20.

Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD: A Secondary Analysis from a Controlled Diet Balance Study.

Stremke ER, McCabe LD, McCabe GP, Martin BR, Moe SM, Weaver CM, Peacock M, Hill Gallant KM.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1002-1012. doi: 10.2215/CJN.00390118. Epub 2018 Jun 19.

21.

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis.

Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM, Yang J, Holland L, di Giuseppe R, Bouma-de Krijger A, Mihaylova B, Herrington WG.

J Am Soc Nephrol. 2018 Jul;29(7):2015-2027. doi: 10.1681/ASN.2017121334. Epub 2018 May 15. Review.

22.

Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.

Moorthi RN, Doshi S, Fried LF, Moe SM, Sarnak MJ, Satterfield S, Schwartz AV, Shlipak M, Lange-Maia BS, Harris TB, Newman AB, Strotmeyer ES.

Nephrol Dial Transplant. 2019 Apr 1;34(4):625-632. doi: 10.1093/ndt/gfy102.

23.

GDF11 induces kidney fibrosis, renal cell epithelial-to-mesenchymal transition, and kidney dysfunction and failure.

Pons M, Koniaris LG, Moe SM, Gutierrez JC, Esquela-Kerscher A, Zimmers TA.

Surgery. 2018 Aug;164(2):262-273. doi: 10.1016/j.surg.2018.03.008. Epub 2018 May 3.

24.

Rationale to reduce calcium intake in adult patients with chronic kidney disease.

Moe SM.

Curr Opin Nephrol Hypertens. 2018 Jul;27(4):251-257. doi: 10.1097/MNH.0000000000000416. Review.

25.

Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility.

Avin KG, Vallejo JA, Chen NX, Wang K, Touchberry CD, Brotto M, Dallas SL, Moe SM, Wacker MJ.

Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E594-E604. doi: 10.1152/ajpendo.00343.2017. Epub 2018 Mar 20.

26.

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

PMID:
29459980
27.

Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways.

Chen NX, O'Neill KD, Moe SM.

Kidney Int. 2018 Feb;93(2):343-354. doi: 10.1016/j.kint.2017.07.019. Epub 2017 Oct 9.

PMID:
29032812
28.

Healthcare outcomes in undocumented immigrants undergoing two emergency dialysis approaches
.

Sher SJ, Aftab W, Moorthi RN, Moe SM, Weaver CS, Messina FC, Martinez-Hoover NM, Anderson MD, Eadon MT.

Clin Nephrol. 2017 Oct;88(10):181-192. doi: 10.5414/CN109137.

29.

Moving Beyond the Assumed: Improving Fistula Success Rates.

Wish JB, Moe SM.

J Am Soc Nephrol. 2017 Oct;28(10):2827-2829. doi: 10.1681/ASN.2017060663. Epub 2017 Jul 21. No abstract available.

30.

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006. Review. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

31.

Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.

Moe SM, Wetherill L, Decker BS, Lai D, Abdalla S, Long J, Vatta M, Foroud TM, Chertow GM.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1128-1138. doi: 10.2215/CJN.11141016. Epub 2017 Jun 19.

32.

Renal Osteodystrophy or Kidney-Induced Osteoporosis?

Moe SM.

Curr Osteoporos Rep. 2017 Jun;15(3):194-197. doi: 10.1007/s11914-017-0364-1. Review.

33.

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.

Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM.

JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468.

34.

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.

Block GA, Bushinsky DA, Cunningham J, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Mix TC, Moe SM, Patel UD, Silver J, Spiegel DM, Sterling L, Walsh L, Chertow GM.

JAMA. 2017 Jan 10;317(2):146-155. doi: 10.1001/jama.2016.19456.

35.

Fractures in Patients with CKD: Time for Action.

Moe SM, Nickolas TL.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1929-1931. Epub 2016 Oct 24. No abstract available.

36.

Calcium Homeostasis in Health and in Kidney Disease.

Moe SM.

Compr Physiol. 2016 Sep 15;6(4):1781-1800. doi: 10.1002/cphy.c150052. Review.

PMID:
27783859
37.

Calcium as a cardiovascular toxin in CKD-MBD.

Moe SM.

Bone. 2017 Jul;100:94-99. doi: 10.1016/j.bone.2016.08.022. Epub 2016 Aug 27. Review.

38.

Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.

Rodenbeck SD, Zarse CA, McKenney-Drake ML, Bruning RS, Sturek M, Chen NX, Moe SM.

Nephrol Dial Transplant. 2017 Mar 1;32(3):450-458. doi: 10.1093/ndt/gfw274.

39.

Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease.

Avin KG, Chen NX, Organ JM, Zarse C, O'Neill K, Conway RG, Konrad RJ, Bacallao RL, Allen MR, Moe SM.

PLoS One. 2016 Aug 3;11(8):e0159411. doi: 10.1371/journal.pone.0159411. eCollection 2016.

40.

Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.

Newman CL, Tian N, Hammond MA, Wallace JM, Brown DM, Chen NX, Moe SM, Allen MR.

Am J Nephrol. 2016;43(1):20-31. doi: 10.1159/000444423. Epub 2016 Feb 17.

41.

Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.

Zhao Y, Chen NX, Shirazi JT, Shen C, Lin SF, Fishbein MC, Moe SM, Chen PS.

Heart Rhythm. 2016 May;13(5):1105-1112. doi: 10.1016/j.hrthm.2015.12.040. Epub 2015 Dec 29.

42.

Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis.

Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):539-46. doi: 10.2215/CJN.06370615. Epub 2015 Nov 27. Review.

43.

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Pun PH, Abdalla S, Block GA, Chertow GM, Correa-Rotter R, Dehmel B, Drüeke TB, Floege J, Goodman WG, Herzog CA, London GM, Mahaffey KW, Moe SM, Parfrey PS, Wheeler DC, Middleton JP.

Hemodial Int. 2016 Jul;20(3):421-31. doi: 10.1111/hdi.12382. Epub 2015 Nov 13.

44.

Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.

Newman CL, Creecy A, Granke M, Nyman JS, Tian N, Hammond MA, Wallace JM, Brown DM, Chen N, Moe SM, Allen MR.

Kidney Int. 2016 Jan;89(1):95-104. doi: 10.1038/ki.2015.315. Epub 2016 Jan 4.

45.

Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease.

Organ JM, Srisuwananukorn A, Price P, Joll JE, Biro KC, Rupert JE, Chen NX, Avin KG, Moe SM, Allen MR.

Nephrol Dial Transplant. 2016 Feb;31(2):223-30. doi: 10.1093/ndt/gfv352. Epub 2015 Oct 5.

46.

Pathophysiology of Vascular Calcification.

Chen NX, Moe SM.

Curr Osteoporos Rep. 2015 Dec;13(6):372-80. doi: 10.1007/s11914-015-0293-9. Review.

PMID:
26409849
47.

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.

Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.

Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.

PMID:
26321176
48.

Low Bone Turnover in Chronic Kidney Disease Is Associated with Decreased VEGF-A Expression and Osteoblast Differentiation.

Chen NX, O'Neill KD, Allen MR, Newman CL, Moe SM.

Am J Nephrol. 2015;41(6):464-73. doi: 10.1159/000438461. Epub 2015 Jul 25.

49.

(18)F-NaF PET Imaging of Early Coronary Artery Calcification.

McKenney-Drake ML, Territo PR, Salavati A, Houshmand S, Persohn S, Liang Y, Alloosh M, Moe SM, Weaver CM, Alavi A, Sturek M.

JACC Cardiovasc Imaging. 2016 May;9(5):627-8. doi: 10.1016/j.jcmg.2015.02.026. Epub 2015 Jul 15. No abstract available.

50.

Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney Disease.

Chaturvedi P, Chen NX, O'Neill K, McClintick JN, Moe SM, Janga SC.

PLoS One. 2015 Jun 26;10(6):e0131589. doi: 10.1371/journal.pone.0131589. eCollection 2015.

Supplemental Content

Support Center